8-K ·Filed Jul 31, 2026

LYB

LyondellBasell Industries N.V.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001489393-26-000057
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The massive EPS beat and strong revenue growth signal a cyclical recovery amplified by supply disruptions. Monitor Middle East developments and operating rate guidance for sustainability. The completion of European asset divestiture improves cost structure but the $734M loss on sale is a one-time drag.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
LYB ▲ +2.56% at T+20d
LONG call ✓ call won +2.56% · α vs SPY -0.43% · entry $62.08 → $63.67
Next anchor: T+60d in 24d
Latest observation: T+41 +7.32% FF3 residual α
Entry anchored
Jul 30, 03:59 PM ET
via exchange tick
T+1d
-2.63%
call -2.63% · α -4.04%
$60.45
settled 2mo ago
T+5d
-4.01%
call -4.01% · α -7.52%
$59.59
settled 8w ago
T+20d
+2.56%
call +2.56% · α -0.43%
$63.67
settled 5w ago
T+60d
—
call — · α —
—
in 24d

Price Chart

Loading chart...

Executive Summary

LyondellBasell reported Q2 2026 EPS excluding identified items of $4.30, a 25.6% beat vs consensus of $3.42, driven by supply constraints from the Middle East conflict that boosted margins across all segments. Revenue of $9.18B slightly missed the $9.29B consensus (-1.2%), but grew 19.8% YoY. The company completed the divestiture of select European assets and generated $752M in operating cash flow.

Key Financial Metrics

EPS
$4.30
est $3.42 · +25.7%
Revenue
$9.2B
est $9.3B · -1.2% · +19.8% YoY
Rating
beat

Key Facts

  • Q2 2026 EPS excluding identified items: $4.30 vs consensus $3.42 (beat 25.6%)
  • Revenue: $9.177B vs consensus $9.29B (miss 1.2%), but up 19.8% YoY from $7.658B
  • EBITDA excluding identified items: $2.127B vs $715M in Q2 2025
  • Completed divestiture of four European assets in May 2026, recording a $734M pre-tax loss on sale
  • Cash from operations: $752M; cash and liquid investments: $2.64B; liquidity: $7.09B
  • OP-Americas segment EBITDA ex-items surged to $1.267B from $318M a year ago
  • No share repurchases in Q2; $224M in dividends paid

Financial Impact

EPS beat of $0.88 (25.6%) on $4.30 vs $3.42 consensus; revenue miss of $113M (1.2%)

epsrevenueebitdaoperating cash flow

Risk Factors

  • Middle East conflict volatility could reverse supply constraints
  • Planned downtime at Clinton facility will impact polyolefins volumes in H2
  • Potential demand deterioration if price outlook causes buying pattern shifts
  • Historical negative stock reaction to earnings despite beats (past reports show avg T+20 -9.5%)

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals
Analyst Consensus
44% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001489393-26-000057
Document: a2026q2ex991_pressrelease.htm0001489393-26-000057
Document: lyb-20260731.htm0001489393-26-000057
Document: 0001489393-26-000057-index-headers.html0001489393-26-000057
Document: 0001489393-26-000057-index.html0001489393-26-000057
Document: 0001489393-26-000057.txt0001489393-26-000057
8-K Data (Synthetic)0001489393-26-000057
12 reports for LYB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for LYB — sortable, filterable
TypeNow
Jul 31, 2026
9w ago
8-K
BULLISH ★ 6/10
$62.08 $63.67▲ +2.56%▼ −0.43%$58.58 (−5.63%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$54.60 $60.62▲ +11.03%▲ +9.69%$58.58 (+7.30%)
Jul 6, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$52.97 $62.08▲ +17.20%▲ +17.76%$58.58 (+10.60%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$67.13 $53.62▼ −20.12%▼ −17.81%$58.58 (−12.72%)
May 22, 2026
19w ago
Press Release
NEUTRAL ★ 2/10
$69.65 $58.52▼ −15.97%▼ −15.81%$58.58 (−15.88%)
May 1, 2026
22w ago
Press Release
MIXED ★ 6/10
$74.75 $67.14▼ −10.17%▼ −15.46%$58.58 (−21.62%)
May 1, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$74.75 $67.14▼ −10.17%▼ −15.46%$58.58 (−21.62%)
Apr 10, 2026
25w ago
Press Release
NEUTRAL ★ 2/10
$73.69 $71.51▼ −2.95%▼ −11.48%$58.58 (−20.49%)
Apr 10, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$73.69 $71.51▼ −2.95%▼ −11.48%$58.58 (−20.49%)
Apr 6, 2026
25w ago
Press Release
NEUTRAL ★ 3/10
$78.60 $75.94▼ −3.38%▼ −12.37%$58.58 (−25.46%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access